LSTA Stock Price History and Quote Analysis Insights for Investors
Lisata Therapeutics, Inc.
Stock Price Today
Lisata Therapeutics, Inc. (LSTA) stock declined over -0.74%, trading at $2.70 on NASDAQ, down from the previous close of $2.72. The stock opened at $2.73, fluctuating between $2.67 and $2.76 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Company Information
| Employees | 25 |
| Beta | 1.22 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Lisata Therapeutics, Inc. (NASDAQ: LSTA) stock price is $2.70 in the last trading session. During the trading session, LSTA stock reached the peak price of $2.76 while $2.67 was the lowest point it dropped to. The percentage change in LSTA stock occurred in the recent session was -0.74% while the dollar amount for the price change in LSTA stock was -$0.02.
The NASDAQ listed LSTA is part of Biotechnology industry that operates in the broader Healthcare sector. Lisata Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. James Nisco
Vice President of Fin. & Treasury
Mr. David Slack MBA
Pres, Chief Bus. Officer & Director
Dr. Kristen K. Buck M.D.
Executive Vice President of R&D and Chief Medical Officer
Ms. Gail Holler
Vice President of HR
Eric Powers
Director of Communications and Marketing
Mr. Gregory S. Berkin
Chief Information Officer
Dr. Ian Zhang MBA, Ph.D.
Pres of NeoStem (China), Inc and Managing Director of NeoStem (China), Inc
Mr. David S. Slack MBA
Pres, Chief Bus. Officer & Director
Mr. John D. Menditto
Vice President of Investor Relations & Corporation Communications
Dr. William K. Sietsema Ph.D.
Vice President of Global Regulatory Affairs
Mr. Tariq Imam
Vice President of Bus. Devel. & Operations and Corporation Counsel
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Pres, Chief Executive Officer & Director
LSTA's closing price is 24.42% higher than its 52-week low of $2.17 where as its distance from 52-week high of $3.83 is -29.5%.
Number of LSTA employees currently stands at 25.
Official Website of LSTA is: https://www.lisata.com
LSTA could be contacted at phone 908 842 0100 and can also be accessed through its website. LSTA operates from 110 Allen Road, Basking Ridge, NJ 07920, United States.
LSTA stock volume for the day was 11.66K shares. The average number of LSTA shares traded daily for last 3 months was 14.57K.
The market value of LSTA currently stands at $22.67M with its latest stock price at $2.70 and 8.39M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com